CoChat

The DOI matches its Crossref record; 54 of the 54 references it cites were found in a registry or an index.

Role of p21-activated kinase pathway defects in the cognitive deficits of Alzheimer disease

Abstract

Defects in dendritic spines are common to several forms of cognitive deficits, including mental retardation and Alzheimer disease. Because mutation of p21-activated kinase (PAK) can lead to mental retardation and because PAK-cofilin signaling is critical in dendritic spine morphogenesis and actin dynamics, we hypothesized that the PAK pathway is involved in synaptic and cognitive deficits in Alzheimer disease. Here, we show that PAK and its activity are markedly reduced in Alzheimer disease and that this is accompanied by reduced and redistributed phosphoPAK, prominent cofilin pathology and downstream loss of the spine actin-regulatory protein drebrin, which cofilin removes from actin. We found that beta-amyloid (Abeta) was directly involved in PAK signaling deficits and drebrin loss in Abeta oligomer-treated hippocampal neurons and in the Appswe transgenic mouse model bearing a double mutation leading to higher Abeta production. In addition, pharmacological PAK inhibition in adult mice was sufficient to cause similar cofilin pathology, drebrin loss and memory impairment, consistent with a potential causal role of PAK defects in cognitive deficits in Alzheimer disease.

Overview

Integrity signals

Registry

Crossref · 10.1038/nn1630

Cites

54 of 54 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 54 references

Cited by

See all 325

Metadata

Authors
Zhao, L., Ma, Q.-L., Calon, F., Harris-White, M. E., Yang, F., Lim, G. P., Morihara, T., Ubeda, O. J., Ambegaokar, S., Hansen, J. E., Weisbart, R. H., Teter, B., Frautschy, S. A., & Cole, G. M.
Affiliations
  • VA Sepulveda Ambulatory Care Center (US)
  • University of California, Los Angeles (US)
  • Centre hospitalier de l'Université Laval (CA)
  • The University of Osaka (JP)
Corresponding author
Cole, Greg M
Venue
Nature Neuroscience
Published
2006-01-15
Volume
9
Issue
2
Pages
234-242
ISSN
  • 1097-6256 (ISSN-L)
  • 1546-1726
OpenAlex
W1985086842
Cited by
317
References
52
Citations by year
2026: 3 · 2025: 7 · 2024: 7 · 2023: 8 · 2022: 9 · 2021: 11 · 2020: 10 · 2019: 8 · 2018: 15 · 2017: 22 · 2016: 16 · 2015: 9 · 2014: 20 · 2013: 22 · 2012: 23
FWCI
17.01
Type
journal article
Language
en
Open access
closed
Licence
www.springer.com/tdm (tdm)
Locations
  • Nature Neuroscience (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • National Institute on Aging (P01AG16570, AG-10415, R01AG016793, P50AG016570, R01AG013741, P50-AG 16570, P50-AG05142, R01AG010685, AG022080, P60AG010415, P50AG005142, AG10685, AG16793, R01 AG13741, R01AG022080)
  • National Institute of Neurological Disorders and Stroke (R01NS043946, NS43946)
Topics
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
  • Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
Keywords
p21-activated kinase, Alzheimer's disease, cognitive impairment, dendritic spines, cofilin, drebrin, actin dynamics, amyloid-beta, amyloid-beta oligomers, hippocampal neurons, memory impairment, synaptic dysfunction
MeSH terms
Alzheimer Disease, Animals, Cells, Cultured, Cognition Disorders, Disease Models, Animal, Female, Humans, Male, Mice, Transgenic, Neuropeptides, Amyloid beta-Peptides, Protein Serine-Threonine Kinases, Dendritic Spines, Actin Depolymerizing Factors, Mice, Rats, p21-Activated Kinases

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Role of p21-activated kinase pathway defects in the cognitive deficits of Alzheimer disease. https://app.cochat.ai/papers/10.1038/nn1630
The paper
Zhao, L., Ma, Q.-L., Calon, F., Harris-White, M. E., Yang, F., Lim, G. P., Morihara, T., Ubeda, O. J., Ambegaokar, S., Hansen, J. E., Weisbart, R. H., Teter, B., Frautschy, S. A., & Cole, G. M. (2006). Role of p21-activated kinase pathway defects in the cognitive deficits of Alzheimer disease. Nature Neuroscience. https://doi.org/10.1038/nn1630

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.